Evaluation of estrogenic potential of flavonoids using a recombinant yeast strain and MCF7/BUS cell proliferation assay

• Published in: PloS one Vol. 8; no. 10; p. e74881
• Main Authors: Resende, Flávia A, de Oliveira, Ana Paula S, de Camargo, Mariana S, Vilegas, Wagner, Varanda, Eliana A
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.10.2013; Public Library of Science (PLoS)
• Subjects: 17β-Estradiol; Assaying; Breast cancer; Cancer; Cardiovascular diseases; Cell cycle; Cell growth; Cell proliferation; Cell Proliferation - drug effects; Cell Survival - drug effects; Chemicals; Diabetes mellitus; DNA, Recombinant - genetics; Estradiol; Estrogen receptors; Estrogenic activity; Estrogens; Evaluation; Flavonoids; Flavonoids - metabolism; Flavonoids - pharmacology; Gene expression; Hormone replacement therapy; Humans; Hydroxyl groups; Hydroxylation; Isoflavones; Kaempferol; Kinases; Ligands; MCF-7 Cells; Menopause; Neurodegeneration; Pharmaceutical sciences; Phytoestrogens; Phytoestrogens - metabolism; Phytoestrogens - pharmacology; Plasmids; Quercetin; Sex hormones; Transcription activation; Xenoestrogens; Yeast; Yeasts - cytology; Yeasts - genetics; Brazil; United States > US
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0074881

Phytoestrogens are of interest because of their reported beneficial effects on many human maladies including cancer, neurodegeneration, cardiovascular disease and diabetes. Furthermore, there is a search for compounds with estrogenic activity that can replace estrogen in hormone replacement therapy during menopause, without the undesirable effects of estrogen, such as the elevation of breast cancer occurrence. Thus, the principal objective of this study was to assess the estrogenic activity of flavonoids with different hydroxylation patterns: quercetin, kaempferol, luteolin, fisetin, chrysin, galangin, flavone, 3-hydroxyflavone, 5-hydroxyflavone and 7-hydroxyflavone via two different in vitro assays, the recombinant yeast assay (RYA) and the MCF-7 proliferation assay (E-screen), since the most potent phytoestrogens are members of the flavonoid family. In these assays, kaempferol was the only compound that showed ERα-dependent transcriptional activation activity by RYA, showing 6.74±1.7 nM EEQ, besides acting as a full agonist for the stimulation of proliferation of MCF-7/BUS cells. The other compounds did not show detectable levels of interaction with ER under the conditions used in the RYA. However, in the E-screen assay, compounds such as galangin, luteolin and fisetin also stimulated the proliferation of MCF-7/BUS cells, acting as partial agonists. In the evaluation of antiestrogenicity, the compounds quercetin, chrysin and 3-hydroxyflavone significantly inhibited the cell proliferation induced by 17-β-estradiol in the E-screen assay, indicating that these compounds may act as estrogen receptor antagonists. Overall, it became clear in the assay results that the estrogenic activity of flavonoids was affected by small structural differences such as the number of hydroxyl groups, especially those on the B ring of the flavonoid.